CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Epidemiology Biomarkers & Prevention 17, 232-238, January 1, 2008. doi: 10.1158/1055-9965.EPI-07-0632
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Sahota, H.
Right arrow Articles by Knight, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sahota, H.
Right arrow Articles by Knight, J. A.

Association of Vitamin D–Related Information from a Telephone Interview with 25-Hydroxyvitamin D

Harleen Sahota1,3, Heidi Barnett1, Maia Lesosky1, Janet M. Raboud1,3,5, Reinhold Vieth2,5 and Julia A. Knight1,3

1 Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute; 2 Department of Pathology and Laboratory Medicine, Mount Sinai Hospital; Departments of 3 Public Health Sciences and 4 Laboratory Medicine and Pathobiology, University of Toronto; 5 University Health Network, Toronto, Ontario, Canada

Requests for reprints: Julia A. Knight, Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, Ontario, Canada M5T 3L9. Phone: 416-586-8701; Fax: 416-586-8404. E-mail: knight{at}mshri.on.ca

Vitamin D may be associated with reduced risks of several types of cancer, including colon, prostate, and breast. We examined the relationship between vitamin D–related questions administered in a telephone interview and serum 25-hydroxyvitamin D [25(OH)D]. Three hundred and eight eligible women were randomly selected from controls in a breast cancer case-control study. Questions pertaining to sun exposure and dietary sources of vitamin D over the previous 4 weeks were asked in both summer and winter. We assessed the association between questionnaire-derived items and 25(OH)D using multiple linear regression. There were 217 participating women, 203 in summer and 213 in winter. Models were adjusted for age, body mass index, and skin color. Number of days when more than 0.5 hour was spent outdoors per week ("7" versus "<7" β = 11.12; P = 0.01), limb coverage ("no" β = 24.90 and "partial" β = 8.15 versus "yes"; P = 0.0001), and milk intake (glasses/wk; ">10" β = 18.94, ">5-10" β = 9.16, and "1-5" β = 7.90 versus "<1"; P = 0.02) best predicted 25(OH)D in the summer. The best predictors in the winter were sunlamp use ("yes" β = 27.97 versus "no"; P = 0.01), milk intake (glasses/wk; ">10" β = 14.54, ">5-10" β = 11.54, and "1-5" β = 2.15 versus "<1"; P = 0.01), and vitamin D–containing supplements ("high" β = 17.30 and "moderate" β = 13.82 versus "none"; P = 0.0006). The R2 was 0.29 for the summer model and was 0.21 for the winter model. Overall, there was evidence to suggest that questions designed to assess vitamin D exposure were in fact related to serum 25(OH)D. (Cancer Epidemiol Biomarkers Prev 2008;17(1):232–8)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.